August 03, 2016
Kite Pharma to Present at the Canaccord Genuity 36th Annual Growth Conference
SANTA MONICA, Calif.--(BUSINESS WIRE)-- Kite Pharma, Inc., (Nasdaq:KITE) today announced that management will present at the Canaccord Genuity 36th Annual Growth Conference.
Event: Canaccord Genuity 36th Annual Growth Conference
Date: Wednesday, August 10, 2016
Time: 2:00 PM Eastern Time
Location: Boston, MA
A live audio webcast will be available on the Investors section of Kite's website, www.kitepharma.com. A replay of the webcast will be available on the website for approximately 30 days.
About Kite Pharma
Kite Pharma, Inc. is a clinical-stage biopharmaceutical company engaged in the development of novel cancer immunotherapy products, with a primary focus on engineered autologous cell therapy (eACT™) designed to restore the immune system's ability to recognize and eradicate tumors. Kite is based in Santa Monica, CA. For more information on Kite Pharma, please visit www.kitepharma.com. Sign up to follow @KitePharma on Twitter at www.twitter.com/kitepharma.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160803006536/en/
Kite Pharma
Greg Mann
VP, Investor Relations
gmann@kitepharma.com
or
For Media:
inVentiv Health
David Polk, 310-309-1029
david.polk@inventivhealth.com
Source: Kite Pharma, Inc.
News Provided by Acquire Media
